Lianna Orlando, PhD

Title: Senior Director of Research

Organization: CureDuchenne

Bio: Lianna Orlando, PhD, is CureDuchenne’s Senior Director of Research, where she helps identify and evaluate strategic investments aimed at developing treatments for Duchenne Muscular Dystrophy. Prior to CureDuchenne, Lianna was at the Muscular Dystrophy Association (MDA), where she oversaw basic, translational, and clinical grant programs, including MDA’s venture philanthropy program, and Fidelity Biosciences Research Initiative (FBRI), focusing on funding research programs in neurodegenerative diseases. Before leaving academia, Lianna was a junior faculty member in the Neurology Department at Massachusetts General Hospital. She completed her doctorate in Neurobiology from Harvard University, and a select master’s degree in Medicine from Harvard Medical School. She has taught both undergraduates and medical students at Harvard, and worked as a freelance science writer for disease foundations and scientific journals. She holds B.S. degrees in Chemistry and in Magazine Journalism from Syracuse University (Summa Cum Laude/Phi Beta Kappa).

2021 FUTURES: Exon Skipping Panel

Information and updates on exon skipping therapies and research from experts in the Duchenne community.

Ash Dugar, PhD

Senior Vice President, Medical Affairs

Dyne Therapeutics

Kevin Eggan, PhD

Group Vice President, Head of Research and Early Development

BioMarin

Leslie Magnus, MD

Vice President, Medical Affairs

NS Pharma

James McArthur, PhD

President and Chief Executive Officer

PepGen

Lianna Orlando, PhD

Senior Director of Research

CureDuchenne

Mark Stahl, MD, PhD

Senior Medical Director, Clinical Development

Avidity Biosciences

Deanna Tucker

Senior Medical Science Liaison

Sarepta Therapeutics